Schwartz Awarded Top ISOPP Honor
Rowena "Moe Schwartz, PharmD, associate professor of pharmacy practice within the James L. Winkle College of Pharmacy and pharmacist for the University of Cincinnati (UC) Cancer Institutes Phase I Experimental Therapeutics Program, received the Helen McKinnon Award at the 2018 International Society of Oncology Practitioners (ISOPP) Annual General Meeting April 12, 2018.
This award was created to honor Helen McKinnon who was instrumental in the formation of ISOPP and is given to those who promote and enhance oncology pharmacy practice worldwide in order to improve cancer patient care.
Schwartz, who joined the Winkle College of Pharmacy in 2016, teaches oncology pharmacy therapeutics and practice and works with students during their advanced pharmacy practice experiences. Additionally, she works as part of the UC Medical Centers oncology pharmacy team at the UC Health Barrett Cancer Center patient care facility in ambulatory oncology.
"This is a pretty incredible accomplishment. (Dr. Schwartz) is a huge asset to our clinics, says Trisha Wise-Draper, PhD, assistant professor of medicine in the Division of Hematology Oncology and medical director of the UC Cancer Institutes Clinical Trials Office.
Tags
Related Stories
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.
Funding expands UC research into weight gain side effects of bipolar medication
August 26, 2026
University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.
One in four NFL players had CTE at death
August 25, 2026
Forbes cites research on concussions and football helmets by the University of Cincinnati in a report that found one in four NFL players had brain damage at death.